USD 10.4 billion
Report ID:
SQMIG35D2140 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
66
|Figures:
75
ADME Toxicology Testing Market size was valued at USD 10.4 billion in 2023 and is poised to grow from USD 11.65 billion in 2024 to USD 28.84 billion by 2032, growing at a CAGR of 12.0% during the forecast period (2025-2032).
The purpose of the ADME toxicology testing market is to evaluate the pharmacokinetics and toxicokinetics of substances, providing vital information on their absorption rates, tissue distribution, metabolism, and elimination pathways. By assessing the potential toxicity and adverse effects of drugs and chemicals, ADME testing helps in early-stage drug development, preclinical safety assessments, and risk management. The driving factor of the ADME toxicology testing market is the increasing demand for safer and more effective drugs. With stringent regulatory requirements and the need to ensure patient safety, pharmaceutical companies and researchers rely on ADME testing to assess the potential toxicity and predict the pharmacokinetic properties of their drug candidates.
Challenges in the ADME toxicology testing market include the complexity of human physiology and interindividual variations, which can influence the outcomes and interpretations of test results. The rapid advancements in drug discovery and development also present challenges in keeping up with the evolving regulatory guidelines and ensuring the accuracy and reliability of ADME testing methods. The global ADME toxicology testing market serves the purpose of evaluating the pharmacokinetics and toxicokinetics of drugs and chemicals, ensuring their safety and efficacy. It is driven by the demand for safer drugs and regulatory compliance. However, challenges such as cost constraints and the need for alternative testing methods exist. Nonetheless, opportunities arise from advancements in in vitro and in silico testing approaches and the potential for personalized medicine applications.
US ADME Toxicology Testing Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 10.4 billion
Largest Segment
Cell Culture
Fastest Growth
Cell Culture
Growth Rate
12.0% CAGR
To get more reports on the above market click here to Buy The Report
Global ADME Toxicology Testing Market is segmented by Method, Technology, Application, End Users and region. Based on Method, the market is segmented into Cellular Assay, Biochemical Assay, In Silica and Ex-vivo. Based on Technology, the market is segmented into Cell Culture, High Throughput, Molecular Imaging and OMICS Technology. Based on Application, the market is segmented into Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Others. Based on End Users, the market is segmented into Hospitals and clinics, Diagnostic centers, Pathological Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
ADME toxicology testing market can further be segmented into the following segments
ADME Toxicology Testing Market By Product & Service
Consumables
Assays
Bacterial Toxicity Assays Enzyme Toxicity Assays
Cell-Based Elisa and Western Blots
Receptor-Binding Assays
Tissue Culture Assays
Other Assays
Services
Equipment
Software
ADME Toxicology Testing Market By Toxicity Endpoint & Test
ADME
Genotoxicity
Skin irritation, Corrosion & Sensitization
Cytotoxicity
Ocular Toxicity
Organ Toxicity
Dermal Toxicity
Phototoxicity
Other End Point & Tests
ADME Toxicology Testing Market By Industry
Pharmaceutical & Biopharmaceutical • Consumer Care
Food
Others
ADME Toxicology Testing Market By Technology
Cell Culture
High-throughput • Toxicogenomics
ADME Toxicology Testing Market By Method
Cellular Assays
Biochemical Assays
Molecular Toxicology Assays
Ex-vivo Models
In Silico Models
ADME Toxicology Testing Market By Region
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe (ROE)
Asia Pacific (APAC)
Japan
China
India
South Korea
Rest of Asia Pacific (ROAPAC)
Latin America
Brazil
Mexico
ROLATAM
Middle East & Africa
Middle East
Africa
To get detailed analysis on other segments, Request For Free Sample Report
North America continues to dominate the global ADME toxicology testing market. The region's dominance is primarily attributed to several factors. Firstly, North America houses a robust pharmaceutical industry with a significant presence of key market players, including pharmaceutical companies, contract research organizations (CROs), and academic research institutions. These entities drive the demand for ADME toxicology testing services to ensure the safety and efficacy of drug candidates. North America boasts advanced healthcare infrastructure, well-established regulatory frameworks, and a strong emphasis on research and development. The region's regulatory bodies, such as the U.S. Food and Drug Administration (FDA), enforce stringent guidelines for drug safety evaluation, making ADME toxicology testing an essential component of the drug development process. This regulatory environment stimulates the demand for toxicology testing services and propels the dominance of North America in the market.
The Asia Pacific region is experiencing significant growth and emerges as the fastest-growing region in the global ADME toxicology testing market. Several factors contribute to the region's rapid expansion. Firstly, the Asia Pacific region has witnessed substantial growth in its pharmaceutical and biotechnology industries, driven by factors such as a large patient population, increasing healthcare expenditure, and rising demand for innovative therapies. Countries like China, India, and Japan have made significant investments in research and development infrastructure, fostering the growth of the ADME toxicology testing market. These nations are becoming preferred destinations for clinical trials and drug development, leading to a surge in the demand for toxicology testing services.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Drug Development Activities
Stringent Regulatory Guidelines
High Cost of ADME Toxicology Testing
Ethical Concerns and Animal Testing Alternatives
Request Free Customization of this report to help us to meet your business objectives.
The global ADME toxicology testing Market features a competitive landscape characterized by the presence of several prominent players offering a range of services and solutions. These companies strive to enhance their market position through continuous innovation, strategic collaborations, and expansions. The competitive landscape is shaped by factors such as technological advancements, regulatory compliance, and the ability to provide comprehensive and reliable toxicology testing services. Strategic collaborations and partnerships also play a crucial role in shaping the competitive landscape of the ADME toxicology testing market. Companies often form alliances with academic institutions, regulatory bodies, and other industry players to gain access to specialized knowledge, expand their service offerings, and establish a global presence. These collaborations facilitate knowledge exchange, technology transfer, and the development of standardized testing protocols, ultimately benefiting the industry as a whole.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global ADME toxicology testing market analysis, the increasing need for effective and safe drugs, stringent regulatory requirements, and the growing focus on personalized medicine are the key growth drivers. Pharmaceutical companies rely on ADME toxicology testing to comply with regulatory guidelines and obtain approvals for clinical trials and product launches. It ensures that drugs are thoroughly evaluated for potential adverse effects and provides valuable insights into their pharmacokinetics and potential interactions with other drugs. The global ADME toxicology testing market is experiencing substantial growth driven by factors like the demand for safe and effective drugs, regulatory compliance, and technological advancements. With the continuous development of innovative testing methods and a focus on regulatory compliance, this market plays a vital role in ensuring the safety and efficacy of pharmaceutical products, ultimately benefiting patients worldwide.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 10.4 billion |
Market size value in 2032 | USD 28.84 billion |
Growth Rate | 12.0% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the ADME Toxicology Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the ADME Toxicology Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the ADME Toxicology Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the ADME Toxicology Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
ADME Toxicology Testing Market size was valued at USD 8.26 Billion in 2023 and is poised to grow from USD 9.21 Billion in 2024 to USD 22.01 Billion by 2032, growing at a CAGR of 11.50% during the forecast period (2025-2032).
The global ADME toxicology testing Market features a competitive landscape characterized by the presence of several prominent players offering a range of services and solutions. These companies strive to enhance their market position through continuous innovation, strategic collaborations, and expansions. The competitive landscape is shaped by factors such as technological advancements, regulatory compliance, and the ability to provide comprehensive and reliable toxicology testing services. Strategic collaborations and partnerships also play a crucial role in shaping the competitive landscape of the ADME toxicology testing market. Companies often form alliances with academic institutions, regulatory bodies, and other industry players to gain access to specialized knowledge, expand their service offerings, and establish a global presence. These collaborations facilitate knowledge exchange, technology transfer, and the development of standardized testing protocols, ultimately benefiting the industry as a whole. 'Charles River Laboratories (US)', 'Covance Inc. (US)', 'Eurofins Scientific (Luxembourg)', 'WuXi AppTec (China)', 'Merck KGaA (Germany)', 'Thermo Fisher Scientific (US)', 'Cyprotex (UK)', 'BioIVT (US)', 'SGS SA (Switzerland)', 'GE Healthcare (US)', 'Promega Corporation (US)', 'Absorption Systems (US)', 'Catalent, Inc. (US)', 'Lonza Group Ltd. (Switzerland)', 'Evotec SE (Germany)', 'Cyagen Biosciences (China)', 'In Vitro ADMET Laboratories LLC (US)', 'HD Biosciences (China)', 'Sekisui XenoTech, LLC (US)', 'Shanghai Medicilon Inc. (China)'
The pharmaceutical industry experienced a surge in drug development activities in 2022, driven by the need for innovative therapeutics and treatments for various diseases. This heightened focus on drug discovery and development directly contributed to the growth of the ADME toxicology testing market. Pharmaceutical companies and research organizations extensively relied on toxicology testing to assess the safety and efficacy of their drug candidates before progressing to clinical trials and market release.
In vitro and In Silico Testing Advancements: The advancement of in vitro and in silico testing methods gained momentum in 2022. These technologies offer alternatives to traditional animal testing and provide efficient, cost-effective, and ethical approaches to toxicology evaluation. The development and adoption of in vitro assays and predictive modeling techniques witnessed notable progress, enabling more accurate and reliable toxicology predictions.
North America continues to dominate the global ADME toxicology testing market. The region's dominance is primarily attributed to several factors. Firstly, North America houses a robust pharmaceutical industry with a significant presence of key market players, including pharmaceutical companies, contract research organizations (CROs), and academic research institutions. These entities drive the demand for ADME toxicology testing services to ensure the safety and efficacy of drug candidates. North America boasts advanced healthcare infrastructure, well-established regulatory frameworks, and a strong emphasis on research and development. The region's regulatory bodies, such as the U.S. Food and Drug Administration (FDA), enforce stringent guidelines for drug safety evaluation, making ADME toxicology testing an essential component of the drug development process. This regulatory environment stimulates the demand for toxicology testing services and propels the dominance of North America in the market.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2140
sales@skyquestt.com
USA +1 351-333-4748